69378 Federal Register / Vol. 69, No. 228 / Monday, November 29, 2004 / Notices 

Contact Person: Yan Z. Wang, PhD, MD, 

Scientific Review Administrator, National 

Institute of Arthritis and Musculoskeletal and 

Skin Diseases, 6701 Democracy Blvd., Suite 

820, Bethesda, MD 20892, (301) 594–4957.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS)

Dated: November 18, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26253 Filed 11–26–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel, Cognitive Neuroscience. 

Date: November 30, 2004. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Richard D. Crosland, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Research, NINDS/NIH/DHHS/Neuroscience 

Center, 6001 Executive Blvd., Suite 3208, 

MSC 9529, Bethesda, MD 20892–9529, (301) 

594–0635, rc218u@nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel, Muscular Dystrophy 

Meeting. 

Date: December 9–10, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Wyndham City Center Hotel, 1143 

New Hampshire Ave., NW., Washington, DC 

20037. 

Contact Person: Rual A. Saavedra, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Research, NINDS/NIH/DHHS, NSC; 6001 

Executive Blvd., Suite 3208, Bethesda, MD 

20892–9529, (301) 496–9223, 

saavedrr@ninds.nih.gov.

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel, HD Therapeutics 

Development. 

Date: December 13–14, 2004. 

Time: 7:30 p.m. to 10 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: W. Ernest Lyons, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, NINDS/NIH/DHHS/

Neuroscience Center, 6001 Executive Blvd., 

Suite 3208, MSC 9529, Bethesda, MD 20892–

9529, (301) 496–4056.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS)

Dated: November 18, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26254 Filed 11–26–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel, Review of 

Research Scientist Development Award—

Research & Training (K01’s), Conference 

(R13’s), and Institutional National Research 

Service Award (T32’s). 

Date: December 10, 2004. 

Time: 8:30 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Double Tree Hotel, 1750 Rockville 

Pike, Rockville, MD 20852. 

Contact Person: Guo HE Zhang, PhD, MD, 

Scientific Review Administrator, National 

Institute of Arthritis and Musculoskeletal and 

Skin Diseases, National Institutes of Health, 

6701 Democracy Boulevard, Suite 800, 

Bethesda, MD 20817, (301) 451–6524, 

zhanggu@mail.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS)

Dated: November 18, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26255 Filed 11–26–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

institutes of Health; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting the Recombinant DNA 

Advisory Committee, December 16, 

2004, 8:30 a.m. to December 17, 2004, 

6 p.m. Bethesda Marriott, 5151 Pooks 

Hill Road, Bethesda, MD 20814 which 

was published in the Federal Register

on November 18, 2004, 69 FR 67597. 

The meeting of the Recombinant DNA 

Advisory Committee has been changed 

to a one-day meeting on December 16, 

2004, from 8:30 a.m. to 4:45 p.m. The 

meeting is open to the public.

Dated: November 19, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26257 Filed 11–26–04; 8:45 am] 

BILLING CODE 4140–01–M